Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Annals of Surgery|November 13, 2018
Multimodal Patient Blood Management Program Based on a Three-pillar Strategy: A Systematic Review and Meta-analysisFriederike C Althoff, Holger Neb, Eva Herrmann, et al.
Future Oncology (London, England)|November 21, 2025
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancerFriederike C Althoff, Fabian Acker, Sebastian Koschade, et al.
BMJ Open|July 22, 2020
Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unitOmid Azimaraghi, Maximilian Hammer, Peter Santer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
Frontiers in Oncology|October 9, 2023
Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancerFriederike C Althoff, Lisa V Schäfer, Fabian Acker, et al.
Academic Radiology|April 27, 2023
Multiparametric Evaluation of Radiomics Features and Dual-Energy CT Iodine Maps for Discrimination and Outcome Prediction of Thymic MassesScherwin Mahmoudi, Leon D Gruenewald, Katrin Eichler, et al.
Clinical Lung Cancer|August 17, 2024
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR InhibitionFabian Acker, Alexandra Klein, Anna Rasokat, et al.
Frontiers in Immunology|March 20, 2026
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patientsSeverine Planel, Guillaume Vayssière, Gianni Maggipinto, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in GermanyJan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Pageof 2